Fulminant hepatic failure associated with propylthiouracil

Annals of Pharmacotherapy

Volumn 37, Issue 2, 2003, Pages 224-228

  Ruiz, Jorge K ^a   Rossi, Giorgio V ^b   Vallejos, Humberto A ^b   Brenet, Rosemarie W ^b   Lopez, Isabel B ^b   Escribano, Alfonso A ^b   Knaack, Jorge Ruiz ^b   Rochefort, Esthel ^b  

^a HOSPITAL CARLOS VAN BUREN   (Chile)

^b NONE

Author keywords

Drug induced hepatitis; Fulminant hepatitis; Hyperthyroidism; Propylthiouracil

Indexed keywords

PROPYLTHIOURACIL;

ADULT; ALCOHOLISM; ARTICLE; AUTOPSY; BLOOD TRANSFUSION; CASE REPORT; DEATH; DRUG ABUSE; EXTRAHEPATIC BILE DUCT OBSTRUCTION; FEMALE; GRAVES DISEASE; HEPATITIS; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; HYPERTHYROIDISM; JAUNDICE; LIVER FAILURE; LIVER NECROSIS; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SPONTANEOUS ABORTION;

EID: 0037314837     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002800303700213     Document Type: Article

References (25)

1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
2. Bernstein D, Tripodi J. Fulminant hepatic failure. Crit Care Clin 1998;14:181-97.
3. Shakil AO, Mazariegos GV, Kramer DJ. Fulminant hepatic failure. Surg Clin North Am 1999;79:77-108.
4. Hanson JS. Propylthiouracil and hepatitis. Two cases and a review of the literature. Arch Intern Med 1984;144:994-6.
5. Criteria of drug induced liver disorders. Report of International Consensus Meeting. J Hepatol 1990;11:272-6.
6. Moseley RH. Evaluation of abnormal liver functions tests. Med Clin North Am 1996;80:887-904.
7. Jonas MM, Eidson MS. Propylthiouracil hepatotoxicity: two pediatric cases and review of the literature. J Pediatr Gastroenterol Nutr 1988;7:776-9.
8. Levy M. Propylthiouracil hepatotoxicity: a review and case presentation. Clin Pediatr (Phila) 1993;32:25-9.
9. Deidiker R, De Mello DE. Propylthiouracil-induced fulminant hepatitis: case report and review of the literature. Pediatr Pathol Lab Med 1996;16:845-52.
10. Williams KV, Nayak S, Becker D, Reyes J, Burmeister LA. Fifty years of experience with propylthiouracil associated hepatotoxicity. What have we learned? J Clin Endocrinol Metab 1997;82:1727-33.
11. Ichiki Y, Akaoshi M, Yamashita M, Morita CH, Maruyama T, Horiuchi T, et al. Propylthiouracil-induced severe hepatitis, a case report and review of the literature. J Gastroenterol 1998;33:747-50.
12. Parker LN. Hepatitis and propylthiouracil. Ann Intern Med 1975;82:228-9.
13. Fedotin MS, Lefer LG. Liver disease caused by propylthiouracil. Arch Intern Med 1975;135:319-21.
14. Mihas AA, Holley P, Koff RS, Hirschowitz BI. Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil. Gastroenterology 1976;70:770-4.
15. Reddy CM. Propylthiouracil and hepatitis: a case report. J Natl Med Assoc 1979;71:1185-6.
16. Weiss M, Hassin D, Bank H. Propylthiouracil-induced hepatic damage. Arch Intern Med 1980;140:1184-5.
17. Ozenirler S, Tuncer C, Boztepe U, Akyol G, Alkim H, Cakir N, et al. Propylthiouracil-induced hepatic damage. Ann Pharmacother 1996;30:960-3.
18. Liaw YF, Huang MJ, Fan KD, Li KL, Wu SS, Chen TJ. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. Ann Intern Med 1993;118:424-8.
19. Westphal SA. Hepatotoxicity from propylthiouracil. South Med J 1994;97:943-7.
20. Safani MM, Tatro DS, Rudd P. Fatal propylthiouracil-induced hepatitis (letter). Arch Intern Med 1982;142:838-9.
21. Limaye A, Ruffolo PR. Propylthiouracil-induced fatal necrosis. Am J Gastroenterol 1987;82:152-4.
22. Coldwell AR, Sando D, Lang S. Propylthiouracil-induced agranulocytosis, toxic hepatitis and death. JAMA 1952;148:639-41.
23. Eisen MJ. Fulminant hepatitis during treatment with propylthiouracil. N Engl J Med 1953;249:814-6.
24. Lock DR, Sthoeger ZM. Severe hepatotoxicity on beginning propylthiouracil therapy. J Clin Gastroenterol 1997;24:267-9.
25. Parker WA. Propylthiouracil-induced hepatotoxicity. Clin Pharmacol 1982;1:471-4.